IP Library Granted Patent US 8,318,481
Granted Patent B2
US 8,318,481 · App. 12/328,971 · Granted Nov 27, 2012

High copy number self-replicating plasmids in pseudomonas

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,318,481
App. No.
12/328,971
Granted
Nov 27, 2012
Kind
B2
Abstract

Provided herein are improved copy number plasmids, particularly those plasmids capable of replication in a bacterial cell. The improved copy number plasmid contain a deletion, insertion, or substitution in the replication control region, particularly a Pseudomonas -specific replication control region, that results in an increase in plasmid copy number in comparison to a control plasmid. Also provided are host cells containing the improved copy number plasmids, as well as methods of using the improved copy number plasmids for the recombinant production of a protein of interest. Further provided are methods for generating plasmids with improved copy number. The methods disclosed herein involve the reiterative selection of improved copy number plasmids by the growth and selection of plasmids capable of growth under increasing selective pressure, wherein the selective pressure is applied utilizing a selection agent to which the control plasmid confers resistance.

Claims (27)

1. A plasmid having an improved copy number compared to a control plasmid, wherein said improved copy number plasmid has a mutation in a replication control region of said improved copy number plasmid relative to the replication control region of said control plasmid, and wherein said control plasmid comprises the replication control region sequence set forth in SEQ ID NO: 1 or a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NO:2, wherein the mutation in said improved copy number plasmid results in a change in the amino acid corresponding to:

a. residue 91 of SEQ ID NO:2, wherein residue 91 is changed to a glycine or a conservative substitution of glycine, and wherein the copy number of the improved copy number plasmid is about 15-fold to about 35-fold higher than that of the control plasmid, or;

b. residue 93 of SEQ ID NO:2, wherein residue 93 is changed to a leucine or a conservative substitution of leucine, and wherein the copy number of the improved copy number plasmid is about 15-fold to about 83-fold higher than that of the control plasmid.

2. The improved copy number plasmid of claim 1 , wherein said improved copy number plasmid comprises a nucleotide sequence selected from the group consisting of:

a) the nucleotide sequence set forth in SEQ ID NO:3 or 5; and,

b) a nucleotide sequence encoding the amino acid sequence set forth in SEQ ID NO:4 or 6.

3. The improved copy number plasmid of claim 1 (a), wherein the copy number of said improved copy number plasmid is about 20-fold to about 35-fold higher than that of said control plasmid.

4. The improved copy number plasmid of claim 3 , wherein the copy number of said improved copy number plasmid is about 25-fold to about 35-fold higher than that of said control plasmid.

5. The improved copy number plasmid of claim 4 , wherein the copy number of said improved copy number plasmid is about 30-fold to about 35-fold higher than that of said control plasmid.

6. The improved copy number plasmid of claim 1 , wherein said improved copy number plasmid and said control plasmid further comprise a selectable marker gene.

7. The improved copy number plasmid of claim 6 , wherein said selectable marker gene confers resistance to kanamycin or gentamycin.

8. The improved copy number plasmid of claim 1 , wherein said improved copy number plasmid further comprises a nucleotide sequence encoding a protein of interest.

9. The improved copy number plasmid of claim 1 , wherein said improved copy number plasmid is capable of replication in a Pseudomonas host cell.

10. The improved copy number plasmid of claim 9 , wherein said Pseudomonas host cell is Pseudomonas fluorescens.

11. A host cell comprising the improved copy number plasmid of claim 1 , wherein said host cell is a Pseudomonas host cell.

12. The host cell of claim 11 , wherein said Pseudomonas host cell is Pseudomonas fluorescens.

13. A method for the recombinant production of a protein of interest comprising introducing the improved copy number plasmid of claim 8 into a Pseudomonas host cell and maintaining said Pseudomonas host cell under conditions sufficient for the expression of the nucleotide sequence encoding the protein of interest.

14. The method of claim 13 , wherein the amount of recoverable protein produced by said Pseudomonas host cell is increased relative to the amount of recoverable protein of said control plasmid, wherein said control plasmid comprises said nucleotide sequence encoding the protein of interest.

15. The improved copy number plasmid of claim 1 (a), wherein the copy number of said improved copy number plasmid is about 30-fold higher than that of said control plasmid.

16. The improved copy number plasmid of claim 1 (b), wherein the copy number of said improved copy number plasmid is about 25-fold to about 83-fold higher than that of said control plasmid.

17. The improved copy number plasmid of claim 16 , wherein the copy number of said improved copy number plasmid is about 35-fold to about 83-fold higher than that of said control plasmid.

18. The improved copy number plasmid of claim 17 , wherein the copy number of said improved copy number plasmid is about 50-fold to about 83-fold higher than that of said control plasmid.

19. The improved copy number plasmid of claim 18 , wherein the copy number of said improved copy number plasmid is about 65-fold to about 83-fold higher than that of said control plasmid.

20. The improved copy number plasmid of claim 19 , wherein the copy number of said improved copy number plasmid is about 70-fold to about 83-fold higher than that of said control plasmid.

21. The improved copy number plasmid of claim 19 , wherein the copy number of said improved copy number plasmid is about 69-fold to about 83-fold higher than that of said control plasmid.

22. The improved copy number plasmid of claim 1 (b), wherein the copy number of said improved copy number plasmid is about 69-fold higher than that of said control plasmid.

23. The improved copy number plasmid of claim 1 (b), wherein the copy number of said improved copy number plasmid is about 83-fold higher than that of said control plasmid.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME AND ASSIGNEE NAME PREVIOUSLY RECORDED ON REEL 023922 FRAME 0301. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT DOCUMENT. Recorded Aug 15, 2013
From: DOW GLOBAL TECHNOLOGIES INC.; THE DOW CHEMICAL COMPANY
To: PFENEX INC.
Reel/Frame 031030/0178 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2010
From: DOW GLOBAL TECHNOLOGIES, INC.; THE DOW CHEMICAL COMPANY
To: PFENEX, INC.
Reel/Frame 023922/0301 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2009
From: CHEW, LAWRENCE C.; LEE, STACEY
To: DOW GLOBAL TECHNOLOGIES INC.
Reel/Frame 022472/0086 →